Meperidine metabolism in the parturient

Area of Science:

• Pharmacology
• Obstetrics
• Drug Metabolism

Background:

• Meperidine is commonly used for intrapartum analgesia.
• Understanding its metabolism during pregnancy is crucial for neonatal safety.
• Previous hypotheses suggest multiple metabolic pathways in pregnant women.

Purpose of the Study:

• To investigate the metabolism of meperidine in term parturients.
• To quantify meperidine and its primary metabolite, normeperidine, in maternal and cord blood.
• To assess the pharmacokinetic profile of intrapartum meperidine administration.

Main Methods:

• Study involved 21 normal parturients at term.
• Meperidine (50 mg IV) administered as the sole analgesic.
• Maternal and cord blood samples analyzed using gas chromatography-mass spectrophotometry.
• Quantification of meperidine and normeperidine levels.

Main Results:

• Most maternal sera exhibited a standard meperidine elimination curve.
• Four patients showed a secondary rise in maternal meperidine levels 30-180 minutes post-injection.
• One patient displayed a notable alteration in normeperidine appearance.
• Cord blood analysis data was not detailed in the abstract.

Conclusions:

• The findings support the hypothesis that pregnant women can metabolize meperidine via multiple pathways.
• Individual variations in meperidine metabolism exist during labor.
• Further research may be warranted to explore these metabolic variations and their clinical implications.